|
|
|
|
|
|
|
Poster: 220
Visits: 71
Title: Dose-Dense Chemoimmunotherapy and Early CNS Prophylaxis for High-Risk DLBCL Interim Results from a Nordic Phase II Study
Authors: Sirpa Lepp ,
Centre: Helsinki University Hospital Cancer Center, Dept of Oncology
|
|
You must be registered to reply or comment.
|
|
DOSE-DENSE CHEMOIMMUNOTHERAPY AND EARLY CNS PROPHYLAXIS FOR HIGH-RISK DLBCL- INTERIM RESULTS FROM A NORDIC PHASE II STUDY
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|